Carnitine Palmitoyl Transferase Deficiency in a University Immunology Practice

被引:5
作者
Bax, Kiley [1 ]
Isackson, Paul J. [2 ]
Moore, Molly [3 ]
Ambrus, Julian L., Jr. [1 ,4 ]
机构
[1] SUNY Buffalo, Dept Med, Sch Med, Buffalo, NY 14222 USA
[2] SUNY Buffalo, Dept Pediat, Sch Med, Buffalo, NY USA
[3] SUNY Buffalo, Dept Surg, Sch Med, Buffalo, NY USA
[4] SUNY Buffalo, Div Allergy Immunol & Rheumatol, Sch Med, Ctr Translat Res, Room 8030C,875 Ellicott St, Buffalo, NY 14203 USA
关键词
Carnitine palmitoyl transferase; Mitochondria; Asthma; Sjogren's syndrome; Raynaud's; Gastrointestinal dysmotility; CEREBRAL VASOCONSTRICTION SYNDROME; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; SJOGRENS-SYNDROME; METABOLIC-CONTROL; CELL-ACTIVATION; IMMUNE-SYSTEM; PATHOGENESIS; LYMPHOCYTES; VASCULITIS;
D O I
10.1007/s11926-020-0879-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose This report describes the clinical manifestations of 35 patients sent to a University Immunology clinic with a diagnosis of fatigue and exercise intolerance who were identified to have low carnitine palmitoyl transferase activity on muscle biopsies. Recent Findings All of the patients presented with fatigue and exercise intolerance and many had been diagnosed with fibromyalgia. Their symptoms responded to treatment of the metabolic disease. Associated symptoms included bloating, diarrhea, constipation, gastrointestinal reflux symptoms, recurrent infections, arthritis, dyspnea, dry eye, visual loss, and hearing loss. Associated medical conditions included Hashimoto thyroiditis, Sjogren's syndrome, seronegative arthritis, food hypersensitivities, asthma, sleep apnea, and vasculitis. This study identifies clinical features that should alert physicians to the possibility of an underlying metabolic disease. Treatment of the metabolic disease leads to symptomatic improvement.
引用
收藏
页数:8
相关论文
共 98 条
  • [91] Metabolic myopathy presenting with polyarteritis nodosa: A case report
    Vishwanath S.
    Abdullah M.
    Elbalkhi A.
    Ambrus Jr. J.L.
    [J]. Journal of Medical Case Reports, 5 (1)
  • [92] Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment
    Vivino, Frederick B.
    Bunya, Vatinee Y.
    Massaro-Giordano, Giacomina
    Johr, Chadwick R.
    Giattino, Stephanie L.
    Schorpion, Annemarie
    Shafer, Brian
    Peck, Ammon
    Sivils, Kathy
    Rasmussen, Astrid
    Chiorini, John A.
    He, Jing
    Ambrus, Julian L., Jr.
    [J]. CLINICAL IMMUNOLOGY, 2019, 203 : 81 - 121
  • [93] A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine
    Wallace, DC
    [J]. ANNUAL REVIEW OF GENETICS, 2005, 39 : 359 - 407
  • [94] Idiopathic chronic fatigue in older adults is linked to impaired mitochondrial content and biogenesis signaling in skeletal muscle
    Wawrzyniak, Nicholas R.
    Joseph, Anna-Maria
    Levin, David G.
    Gundermann, David M.
    Leeuwenburgh, Christiaan
    Sandesara, Bhanuprasad
    Manini, Todd M.
    Adhihetty, Peter J.
    [J]. ONCOTARGET, 2016, 7 (33) : 52695 - 52709
  • [95] Mitochondrial damage-associated molecular patterns and vascular function
    Wenceslau, Camilla Ferreira
    McCarthy, Cameron G.
    Szasz, Theodora
    Spitler, Kathryn
    Goulopoulou, Styliani
    Webb, R. Clinton
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (18) : 1172 - U16
  • [96] Host mitochondria influence gut microbiome diversity: A role for ROS
    Yardeni, Tal
    Tanes, Ceylan E.
    Bittinger, Kyle
    Mattei, Lisa M.
    Schaefer, Patrick M.
    Singh, Larry N.
    Wu, Gary D.
    Murdock, Deborah G.
    Wallace, Douglas C.
    [J]. SCIENCE SIGNALING, 2019, 12 (588)
  • [97] Mitochondrial Dysfunction in Migraine
    Yorns, William R., Jr.
    Hardison, H. Huntley
    [J]. SEMINARS IN PEDIATRIC NEUROLOGY, 2013, 20 (03) : 188 - 193
  • [98] Mitochondria in vascular disease
    Yu, Emma
    Mercer, John
    Bennett, Martin
    [J]. CARDIOVASCULAR RESEARCH, 2012, 95 (02) : 173 - 182